Thill, M., Wimberger, P., Grafe, A., Klare, P., Luedtke-Heckenkamp, K., Reichert, D., . . . Schneeweiss, A. (2022). Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: Results from a German non-interventional study (NIS) HELENA (NCT01777958). Breast cancer research and treatment, 196(2), . https://doi.org/10.1007/s10549-022-06710-4
Chicago-Zitierstil (17. Ausg.)Thill, Marc, et al. "Dual HER2 Blockade with Pertuzumab (P) and Trastuzumab (T) in Patients with HER2-positive Metastatic Breast Cancer (mBC) Relapsing After Adjuvant Treatment with T: Results from a German Non-interventional Study (NIS) HELENA (NCT01777958)." Breast Cancer Research and Treatment 196, no. 2 (2022). https://doi.org/10.1007/s10549-022-06710-4.
MLA-Zitierstil (9. Ausg.)Thill, Marc, et al. "Dual HER2 Blockade with Pertuzumab (P) and Trastuzumab (T) in Patients with HER2-positive Metastatic Breast Cancer (mBC) Relapsing After Adjuvant Treatment with T: Results from a German Non-interventional Study (NIS) HELENA (NCT01777958)." Breast Cancer Research and Treatment, vol. 196, no. 2, 2022, https://doi.org/10.1007/s10549-022-06710-4.